The ARV Therapies and Therapeutic Strategies program is a comprehensive, independent review of the 22nd International AIDS Conference (AIDS 2018). This program consists of four components: (1) CME Internet Symposium: AIDS 2018 Expert Review: a 1.5 hour Internet symposium that features an overview and discussion of key presentations and posters, selected by the expert faculty discussants; (2) European Perspective on AIDS 2018: a 1 hour panel discussion featuring Europe-based expert faculty reviewing and discussing key presentations with a focus on clinical management and treatment in the EU; (3) Rapid-Fire Review of AIDS 2018: a podcast that provides a brief, audio summary of the most essential data presented at the conference; and (4) From Conference to Clinic: Reviewing and Applying Data From AIDS 2018: case-based dinner meetings during which the key data are reviewed, discussed and applied to patient care.
From Conference to Clinic: Reviewing and Applying Data From AIDS 2018 is an interactive, case-based dinner program series designed to highlight and discuss the clinical significance and application of new findings in HIV medicine presented at AIDS 2018. Because the focus of the dinner programs will be on case studies and applying the data presented at AIDS 2018 in a clinical setting, prior to attending a dinner program participants will be asked to view the CME Internet Symposium: AIDS 2018 Expert Review, which will familiarize them with the AIDS 2018 data and serve as a comprehensive conference overview and summary. As a result of this blended learning approach, participants will gain an increased understanding of key data presented at AIDS 2018 and be better prepared to address their HIV patients' health needs and provide optimal care in a clinical setting.
All online components of the program will be accessible at www.viraled.com
This program is produced by the Postgraduate Institute for Medicine and ViralEd, Inc. It is not a session created by or presented at AIDS 2018 and it is not sanctioned by the organizers of AIDS 2018.
This activity has been designed to meet the educational needs of physicians, physician assistants, advanced practice nurses and other health care professionals involved in the care of patients with HIV infection.
After completing this activity, the participant should be better able to:
Review data reported at AIDS 2018 for counseling, testing and antiretroviral treatment to prevent HIV infection, especially in underserved communities
Employ strategies based on studies and data presented at AIDS 2018 for helping HIV-positive patients in medically underserved communities link to and stay in appropriate and effective HIV care
Discuss with patients and colleagues the studies and data on therapies for HIV/AIDS presented at AIDS 2018 and use that discussion to decide on appropriate planning of therapy for patients with HIV/AIDS
6:00 - 6:30 PM: Check-in/Walk-in Registration
6:30 - 8:30 PM: Program and Q&A
|
Roberto C. Arduino, MD |
Antonio E. Urbina, MD Medical Director Institute for Advanced Medicine Mt. Sinai St. Luke's and Mt. Sinai Roosevelt Hospitals New York, New York |
|
Dushyantha T. Jayaweera, MD |
Jeffrey Burack, MD Co-Medical Director East Bay AIDS Center Oakland, California |
|
Michael Sension, MD |
Anthony Mills, MD Southern California Men's Medical Group Los Angeles, California |
|
Ian Frank, MD |
 |
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and ViralEd, Inc. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. |
| The Postgraduate Institute for Medicine designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. | |
The Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.
As of August 1, 2013, pharmaceutical companies are required by the open payments act (AKA Sunshine Act) to account for certain transfers of value provided to physicians. The federal guidance for the Sunshine Act provides exceptions for CME expenses that meet certain criteria. We believe the program to which you are invited meets these exceptions, and therefore we will not be collecting, nor reporting, any information gathered from this program. If federal guidance is further clarified in the future, we will then provide that information to the supporting pharmaceutical companies to the best of our ability.
This activity is supported by an independent educational grant from Gilead Sciences Medical Affairs.
This coverage is not sanctioned by the conference organizers and is not an official part of the conference proceedings.
